top of page
  • Writer's pictureAbacus Research

Align Technology: not going down on bad numbers

Align is a dental consumer products company that has been struggling in the post Covid world.

  • 2022 downgrades were part of the pandemic dislocation & management’s over-optimism.

  • We believe, ALGN’s business model and competitive position have not been impaired.

  • We see the potential for earnings growth to rebound to 30% over 2022-25 driven by a recovery in revenue growth and operating margins.

  • The multiple is below historical average and low relative to peers, hence why we see 78% upside potential over a couple of years.

Potential Upside: $514 (+78%)

Sensible Downside: $230(-20%)

Recent Posts

See All

Fortive: potential14% IRR

Fortive is a high quality business with an asset light model, high margins, high incremental margins and consistent FCF generation that is reinvested in M&A. Recent guidance for slow organic growth fo

Vertiv (VRT) - Datacentre play on AI theme

Vertiv is a leader in critical infrastructure for datacentres and a clear beneficiary of AI driven growth. AI tailwind for datacentres is only starting. To date, Vertiv has seen little to no impact fr

Palantir (PLTR)

The advent of LLM’s have changed Palantir's relationships with institutions – the commercial market is now open to what Palantir is selling. This is a significant change from one year ago. AIP bootcam


bottom of page